Bispecific CAR T-cell therapy: combining anti-CD19 and CD22 CAR T-cells
Primary analysis of MURANO study data for R/R CLL
Where will leukemia research go next?
Breaking news from the ALCYONE study of VMP plus daratumumab for NDMM
Maria Victoria Mateos
Azacitidine/HDAC inhibitor combination for high risk AML: a promising pilot study